A Smart + Strong Site
Subscribe to:
POZ magazine

Back to home » Treatment News » Top Stories

Most Popular Stories
Undetectable Viral Load Essentially Eliminates Transmission Risk in Straight Couples
FDA Approves New Single-Tablet HIV Regimen, Triumeq
Life Expectancy for Young People With HIV Is Nearly Normal
A 15-Year Jump in Life Expectancy for People With HIV
Scientists Devise Method of Snipping HIV From Immune Cells
Monkey HIV Vaccine Success Opens Door for Human Trials
HIV Combo Pill Less Toxic Thanks to New Form of Tenofovir
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to news@aidsmeds.com.

Click here for more news


January 3, 2008

Peripheral Arterial Disease Risk Found in People With HIV

HIV-positive people face an increased risk of heart attacks and strokes due to clogging of the major blood vessels, and two studies have found variable rates of a related condition, peripheral artery disease (PAD), in two groups of HIV-positive people.

In PAD, blood vessels carrying oxygen-rich blood to the kidneys, stomach, arms, legs or feet become restricted by arteriosclerosis—thickening and hardening of the artery walls caused by excess cholesterol. Left untreated, PAD can cause claudication—cramping, fatigue and discomfort in the legs—and potentially serious kidney damage. 

In the first study, published as a letter to the editor in the Journal of Acquired Immune Deficiency Syndromes, Enrique Bernal, MD, of the Infectious Diseases Unit Hospital General Universitario de Elche Universidad Miguel Hernández in Elche, Spain, and his colleagues assessed PAD in 112 HIV-positive patients, who had two or more traditional heart disease risk factors.

To diagnose PAD, the researchers determined each patient’s ankle-brachial index—a measure of the blood pressure in the arteries supplying the legs, compared with the blood pressure in the arms. A low ankle-brachia index reading, 0.9 or less, indicates narrowing of the arteries and has been linked to an increased risk of heart disease. A high index reading, 1.4 or more, may also carry a higher risk of heart disease.

Bernal’s team found an unusually low rate of PAD in this cohort of patients. Though the rate of PAD in a general population of people with heart disease risks ranges from 5 to 30 percent, the team found a low brachia index reading in only 3.5 percent of the 112 patients, despite the fact that nearly 29 percent of the patients had four or more known heart disease risk factors.

The researchers could not explain this lower-than-expected rate of PAD, but they encourage physicians to conduct this relatively easy test in HIV-positive patients at risk for heart disease. The team did not state if any of the patients had a high ankle-brachia index reading.

In a similar study with slightly different results published in HIV Medicine, Anjali Sharma, MD, of the department of medicine at Downstate Medical Center, State University of New York in Brooklyn, and her colleagues assessed heart disease risk and looked for PAD in 335 participants in the Women’s Interagency HIV Study (WIHS).

Sharma’s team also found lower-than-expected proportions of women with a low ankle-brachia index reading. Fewer than 1 percent of the women, had an index of 0.9 or less. A high ankle-brachia index reading was found in 6.9 percent of the women, however—a rate that was higher than expected.

The team is encouraging others to conduct similar studies to determine the clinical impact, specifically of high ankle-brachia index readings. Also, these two studies stand in contrast to an abstract presented this past September at the 47th Interscience Conference on Anitimicrobial Agents and Chemotherapy in Chicago, wherein researchers found PAD in almost 21 percent of the patients studied.

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team reviews all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (2 total)

[Go to top]

Quick Links
About HIV and AIDS
The Cure
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Conference Coverage
Health Services Directory
POZ Magazine
AIDSmeds on Twitter

Conference Coverage

XX International AIDS Conference
(AIDS 2014)
Melbourne, Australia
July 20 - 25, 2014

21st Conference on Retroviruses and Opportunistic Infections
(CROI 2014)
Boston, MA
March 3 - 7, 2014

7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention
(IAS 2013)
Kuala Lumpur, Malaysia
June 30 - July 3, 2013

more conference coverage

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.